GlassScriptPhysician profile
Lia Trojansky
NPI 1417306002
$2,917.61
in general payments reported to CMS, 2019-2025
23 companies · $464 in 2025
The $464 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $453 · 2022: $764 · 2023: $954 · 2024: $283 · 2025: $464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,701.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $988.09 | 2021-2025 | |
| Merz North America, INC. | $462.59 | 2021-2023 | |
| Amgen INC. | $353.11 | 2022-2024 | Otezla |
| Abbvie INC. | $224.22 | 2022-2025 | |
| Lilly USA, LLC | $152.53 | 2021-2022 | |
| Pfizer INC. | $132.63 | 2021-2023 | |
| Botanix Sb INC | $78.28 | 2025 | Sofdra |
| Regeneron Healthcare Solutions, INC. | $60.44 | 2021-2025 | Libtayo |
| Sun Pharmaceutical Industries INC. | $55.50 | 2021-2025 | Absorica Ld, Winlevi |
| Allergan, INC. | $51.34 | 2022 | |
| Dermavant Sciences, INC. | $47.64 | 2024 | Vtama |
| Fidia Pharma USA INC. | $40.43 | 2024-2025 | |
| Ucb, INC. | $36.94 | 2024 | Bimzelx |
| Janssen Biotech, INC. | $34.16 | 2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $33.09 | 2024 | Clear+Brilliant |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Epi Health, LLC | $30.60 | 2021 | |
| Medline Industries LP | $25.08 | 2022 | |
| Leo Pharma INC. | $22.11 | 2025 | Anzupgo |
| Vyne Pharmaceuticals INC. | $20.85 | 2021 | |
| Genzyme Corporation | $19.71 | 2021 | |
| Cipher Pharmaceuticals US LLC | $16.72 | 2025 | Spinosad, Natroba |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.55 | 2021 | |
| Mission Pharmacal Company | $15.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lia Trojansky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.